Cas:629-83-4 methyl melissate manufacturer & supplier

Chemical Name:methyl melissate

CAS.NO:629-83-4

Synonyms:EINECS 211-113-1;methyl triacontanoate;MFCD00042897

Molecular Formula:C₃₁H₆₂O₂

Molecular Weight:466.82300

HS Code:2915900090

Physical and Chemical Properties:

Melting point:70-73 °C

Boiling point:475.8ºC at 760 mmHg

Density:0.858g/cm3

Index of Refraction:1.454

PSA:26.30000

Exact Mass:466.47500

LogP:11.10210

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like EINECS 211-113-1 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD00042897 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,EINECS 211-113-1 Use and application,EINECS 211-113-1 technical grade,usp/ep/jp grade.

Related News: The pharmaceutical industry is related to the national economy and the people’s livelihood. The entire upstream and downstream areas involve all aspects of the national economy. Our government has a long-term direct or indirect policy preference for this. methyl melissate manufacturer Over the past twelve months, the collaboration team has worked to optimize its processes for making T cells from iPSCs, and has now shown the production of pure T-lymphocytes consisting of both CD8+ and CD4+ T cells having a global gene expression profile that is highly-similar to primary T cells based on a principal component analysis. methyl melissate supplier Pre-approval Access Programs (also known as expanded access, early access, compassionate use, named patient supply) are regulatory-compliant processes permitting experimental agents in development to be made available upon the request of a physician or a patient for appropriate patients for whom no alternative treatment option exists in their country. methyl melissate vendor Over the past twelve months, the collaboration team has worked to optimize its processes for making T cells from iPSCs, and has now shown the production of pure T-lymphocytes consisting of both CD8+ and CD4+ T cells having a global gene expression profile that is highly-similar to primary T cells based on a principal component analysis. methyl melissate factory Over the past twelve months, the collaboration team has worked to optimize its processes for making T cells from iPSCs, and has now shown the production of pure T-lymphocytes consisting of both CD8+ and CD4+ T cells having a global gene expression profile that is highly-similar to primary T cells based on a principal component analysis.